Kiora Pharmaceuticals, Inc. (KPRX)
NASDAQ: KPRX · Real-Time Price · USD
1.230
-0.100 (-7.52%)
At close: Nov 13, 2026, 4:00 PM EST
1.250
+0.020 (1.63%)
After-hours: Nov 13, 2026, 4:25 PM EST
Kiora Pharmaceuticals Employees
Kiora Pharmaceuticals had 13 employees as of December 31, 2025. The number of employees increased by 1 or 8.33% compared to the previous year. That makes Kiora Pharmaceuticals the 39,690th largest employer in the world and 5,833rd in the United States.
Employees
13
Change (1Y)
1
Growth (1Y)
8.33%
Revenue / Employee
$76,923
Profits / Employee
-$981,772
Market Cap
7.83M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 13 | 1 | 8.33% |
| Dec 31, 2024 | 12 | 0 | - |
| Dec 31, 2023 | 12 | 0 | - |
| Dec 31, 2022 | 12 | -2 | -14.29% |
| Dec 31, 2021 | 14 | 0 | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Vistagen Therapeutics | 41 |
| Longeveron | 38 |
| Cerenome | 28 |
| Moleculin Biotech | 17 |
| CalciMedica | 15 |
| Soligenix | 14 |
| Ensysce Biosciences | 10 |
| AEON Biopharma | 8 |
KPRX News
- 3 days ago - Kiora Pharmaceuticals Quarterly report: Q3 2026 - Filings
- 3 days ago - Kiora Pharmaceuticals Earnings release: Q3 2026 - Filings
- 17 days ago - Kiora Pharmaceuticals Slides: Corporate presentation - Filings
- 2 months ago - Kiora Pharmaceuticals Licenses South Korean Ophthalmic Development and Commercialization Rights for KIO-301 to Chong Kun Dang Pharmaceutical Corporation - Newsfile Corp
- 3 months ago - Kiora Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Corporate Update - Newsfile Corp
- 3 months ago - Kiora Pharmaceuticals Quarterly report: Q2 2026 - Filings
- 3 months ago - Kiora Pharmaceuticals Earnings release: Q2 2026 - Filings
- 3 months ago - Kiora Pharmaceuticals Slides: Q2 2026 - Filings